We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Thermo Fisher Webinar Technology Networks 18th July 2024

Innovations in Mycoplasma and Sterility Testing for Biopharma

Sterility and mycoplasma testing in biotherapies, particularly cell therapy products, is critical. Developing an analytical strategy to detect contaminants such as mycoplasma can present several challenges.

In this webinar, our expert speakers will discuss the types of analytical testing that can be effectively employed in the early stages of therapeutic development and subsequently scaled to meet production challenges. You’ll learn how to leverage rapid mycoplasma and sterility detection techniques early on in the therapy development workflow, which can significantly contribute to instilling confidence in the final product by facilitating the early detection of potential contamination.

Attend this webinar to discover:

  • Strategies to overcome the challenges of traditional methods for product safety testing in cell therapy products
  • The feature and benefits of using rapid detection techniques
  • Learn how the throughput of our assays are scalable in order to meet or accommodate the increased testing requirements or needs following commercialization
  • The latest regulatory guidelines for product safety testing in cell therapies
Sharon Rouw
Sharon Rouw
Sr. Product Manager, Bioproduction Group - Pharma Analytics
Thermo Fisher Scientific
Michael Brewer
Michael Brewer
Director, Global Principal Consultant, Regulatory
Thermo Fisher Scientific
Brought to you by
Register for FREE Now!
Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
Want to invite a colleague?

Click the button below to begin inviting a colleague to this Webinar